Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors - Wikidata - wikimedia - TriplyDB

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

http://www.wikidata.org/entity/Q29618610

about

Profiling critical cancer gene mutations in clinical tumor samples Imatinib mesylate for gastrointestinal stromal tumours (GISTs)Imatinib mesylate for gastrointestinal stromal tumours (GISTs)Imatinib mesylate for gastrointestinal stromal tumours (GISTs)Imatinib mesylate for gastrointestinal stromal tumours (GISTs)Imatinib mesylate for gastrointestinal stromal tumours (GISTs)Nilotinib and MEK inhibitors induce synthetic lethality through paradoxical activation of RAF in drug-resistant chronic myeloid leukemia Tumor-intrinsic and -extrinsic roles of c-Kit: mast cells as the primary off-target of tyrosine kinase inhibitors Anaplastic lymphoma kinase: signalling in development and disease Sorafenib inhibits growth and mitogen-activated protein kinase signaling in malignant peripheral nerve sheath cells Jakinibs: a new class of kinase inhibitors in cancer and autoimmune disease Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations Phase I study of the safety, tolerability, and pharmacokinetics of oral CP-868,596, a highly specific platelet-derived growth factor receptor tyrosine kinase inhibitor in patients with advanced cancers Transcriptome sequencing to detect gene fusions in cancer A conserved protonation-dependent switch controls drug binding in the Abl kinase Lestaurtinib (CEP701) is a JAK2 inhibitor that suppresses JAK2/STAT5 signaling and the proliferation of primary erythroid cells from patients with myeloproliferative disorders Discovery of a fusion kinase in EOL-1 cells and idiopathic hypereosinophilic syndrome Combined surgical and molecular therapy: the gastrointestinal stromal tumor model Structural reengineering of imatinib to decrease cardiac risk in cancer therapy Spontaneous rupture of giant gastric stromal tumor into gastric lumen Gleevec (STI-571) inhibits lung cancer cell growth (A549) and potentiates the cisplatin effect in vitro Carcinogenesis: The more we seek to know the more we need to know - Challenges in the post Genomic Era Cerebral relapse of metastatic gastrointestinal stromal tumor during treatment with imatinib mesylate: case report Genetic alteration and mutation profiling of circulating cell-free tumor DNA (cfDNA) for diagnosis and targeted therapy of gastrointestinal stromal tumors FGFR3-TACC3 fusion in solid tumors: mini review Targeted therapy of gastrointestinal stromal tumours More than a Decade of Tyrosine Kinase Inhibitors in the Treatment of Solid Tumors: What We Have Learned and What the Future Holds Emerging Agents for the Treatment of Advanced, Imatinib-Resistant Gastrointestinal Stromal Tumors: Current Status and Future Directions Personalized Medicine in Gastrointestinal Stromal Tumor (GIST): Clinical Implications of the Somatic and Germline DNA Analysis Clinical implementation of comprehensive strategies to characterize cancer genomes: opportunities and challenges Cellular targeting in autoimmunity Review article: the biology, diagnosis and management of gastrointestinal stromal tumours The GIST of targeted therapy for malignant melanoma New drugs for prostate cancer Targeting molecular addictions in cancer Primary gastrointestinal stromal tumors: Current advances in diagnostic biomarkers, prognostic factors and management of its duodenal location Systemic treatment-induced gastrointestinal toxicity: incidence, clinical presentation and management Next-generation clinical trials: Novel strategies to address the challenge of tumor molecular heterogeneity Targeting EML4-ALK driven non-small cell lung cancer (NSCLC)Platelet-derived growth factor: a key factor in the pathogenesis of graves' ophthalmopathy and potential target for treatment

P2860

Q21562343-0AB2DCD4-AC85-4E1D-A856-23AB8BD3C7AC Q24200254-AD113489-A869-4899-82FD-0A4EF2A3D109 Q24234239-186CB2F4-8F4C-4494-8CF1-8E3DC22A3B79 Q24234579-14246950-2FE0-4E56-9251-570E2F60ACD1 Q24235034-805BE33C-2B1A-461E-AE28-A14D976654DA Q24240660-A6846447-6874-4BDB-AF71-3BE490C3FCEC Q24299821-DC985B29-7025-4E2D-A714-34AA8B72CC2E Q24306212-A0161057-CC39-4FEF-BE0F-CA4DC84442DF Q24312329-F3010D2F-1F11-4330-AE59-EB53BAD4FD40 Q24602021-00316250-5AFD-4DD8-AA93-39DB49E365FC Q24617270-65C2D86B-8D6B-4D6B-985D-7CD14344A5E8 Q24632064-FC389280-3A66-4743-B669-118C5738001E Q24644683-D652826D-D918-4D6A-989F-C2F9C4DE99AB Q24653386-4274771C-D7F0-4B5F-AFDC-5E4EA2AB7280 Q24657421-B0728A5A-DCBF-4942-A10B-E6850DFC911B Q24657681-5B8E2B5A-CB5F-4833-9A73-BF53F4EF2ECE Q24670121-A8A623DF-DC79-434A-8AFC-C749C6B65C02 Q24675987-050372AF-013C-42CE-A4EE-632E28354E74 Q24685557-3D6AAE08-3322-4DD7-A7C1-10D171195CB1 Q24793072-8E1A942D-804B-4EB7-8B91-C40029A9E6AB Q24799983-B70AB34E-2F39-4671-B31C-DEB18B416B89 Q24801574-277521EA-17C9-456A-B8D8-263329065906 Q24804492-504CE372-2562-4FB3-9198-A1033006ED57 Q26738567-FADCDEC7-794B-4B01-A2F6-127568DE6605 Q26740578-E14B62BF-39EE-4E8F-A042-BF7B63CAC881 Q26745633-E719FF77-0685-4EF8-8BCB-17D5EF3DA4C4 Q26781662-2CD75130-7283-4E05-855A-219E37ED7F89 Q26799387-F1DF2B32-FBEF-4ECA-BCCD-36B0BA78F342 Q26800005-FC9A9E11-021D-4176-AB19-653ADDC6E6D9 Q26823978-915F1E7B-91CD-418F-AF75-0822252E35F9 Q26824580-C585E345-F01C-4D2A-89D6-1C8CABDD160B Q26825310-0388ADE9-14D3-4567-9DC5-B089E049C28F Q26827092-55799611-5502-416D-9F79-70DAA6AAB041 Q26827515-2F1F839B-589A-4D7F-9EE0-E34DCB0B8637 Q26829525-C90F421F-ABF6-4FF1-80BA-748FF0FF4A58 Q26829970-4EE5D38F-2E40-4446-A24B-B7EADA5BBEF4 Q26830695-0F7D6DAC-A344-415E-ABEE-21473690AA19 Q26992272-2DA9EA34-8339-4100-9169-BFD29F7540AD Q27002155-4623A24E-9256-4A2D-8785-6F37701D57A5 Q27005680-1C535182-D6B2-4FE1-8A13-6D1001F4A50C

P2860

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

http://www.wikidata.org/entity/Q29618610

description

2002 nî lūn-bûn

@nan

2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

@ast

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

@en

type

label

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

@ast

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

@en

prefLabel

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

@ast

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

@en

P1433

Q29618610-B09F4309-9067-4E4A-B768-8CC0FAB00AF6

P1476

Q29618610-D01901C0-9F5B-4E42-99DD-0600995274BA

P2093

Q29618610-0FA1C160-57BC-486E-A03B-4805C21A3278

Q29618610-109EF72F-2CFD-4122-B675-581033F47084

Q29618610-19A7F8D0-C2D1-40BF-B217-D7E5A5B9A807

Q29618610-32F1C98A-5BB0-4A25-B770-7D5DF10C4186

Q29618610-55DDB24E-CDB0-4CF6-B87E-982E2CF7D478

Q29618610-5C8489CD-B636-40EA-9546-7FD01ACCC5F8

Q29618610-67047914-012A-481C-A29D-238C1DCD88C3

Q29618610-695E2CBB-F27B-4BE9-A833-52D35568F91E

Q29618610-73829880-F0CB-4A12-BF81-055D1338813F

Q29618610-76C884D4-9D39-48C7-B698-35C46B6012ED

P304

Q29618610-875D8945-9E73-4A32-BD2E-92E4A7D46E74

P31

Q29618610-780E38C4-F063-4D07-86ED-07B4B654FAB0

P3181

Q29618610-D038F336-063F-47FB-BA1B-926CDF4AC955

P356

Q29618610-7BD5C9F9-766D-4CEB-9E84-5235D4A84518

P407

Q29618610-767D0C7C-C48E-46D0-A615-EA7FD478A4F4

P433

Q29618610-A77D8426-8608-4311-AC43-925268EBA6AC

P478

Q29618610-D57DC9B7-0DA6-469D-9C6A-7137CC1ECC3B

P50

Q29618610-37A6F1C5-2563-4EFE-AE74-0F2A0932AC3B

Q29618610-73B2124B-A63B-401D-B459-B32C347867CA

Q29618610-DF0F33EC-A451-4DB5-AA02-DFDC5E19B117

Q29618610-EC106516-9B86-46B9-8BCE-061C0357A7DB

P577

Q29618610-61BE385A-61D8-4B97-8DBF-DE2821172D5B

P698

Q29618610-CC5AD54D-B238-4349-A4B3-448DA5B1A05B

P3181

P356

P1433

The New England Journal of Medicine

P1476

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

@en

P2093

Annick D Van den Abbeele

http://www.w3.org/2001/XMLSchema#string

Beate Kiese

http://www.w3.org/2001/XMLSchema#string

Bin Peng

http://www.w3.org/2001/XMLSchema#string

Burton Eisenberg

http://www.w3.org/2001/XMLSchema#string

Charles D Blanke

http://www.w3.org/2001/XMLSchema#string

Christopher Corless

http://www.w3.org/2001/XMLSchema#string

Christopher D M Fletcher

http://www.w3.org/2001/XMLSchema#string

George D Demetri

http://www.w3.org/2001/XMLSchema#string

Heikki Joensuu

http://www.w3.org/2001/XMLSchema#string

Jonathan A Fletcher

http://www.w3.org/2001/XMLSchema#string

P304

472-480

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1917871

http://www.w3.org/2001/XMLSchema#string

P356

10.1056/NEJMOA020461

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

347

http://www.w3.org/2001/XMLSchema#string

P50

Brian J. Druker

Michael C. Heinrich

P577

2002-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12181401

http://www.w3.org/2001/XMLSchema#string